Details for New Drug Application (NDA): 215338
✉ Email this page to a colleague
NDA 215338 describes VANCOMYCIN HYDROCHLORIDE, which is a drug marketed by Abon Pharms Llc, Fresenius Kabi Usa, Lupin Ltd, Orient Pharma Co Ltd, Strides Pharma, Watson Labs, Alkem Labs Ltd, Amneal, Aspiro, Avet Lifesciences, Eugia Pharma, Gland, Hikma, Hikma Pharms, Hospira, Hospira Inc, Knack, Medimetriks Pharms, Meitheal, Mylan Labs Ltd, Plano Pharms, Sagent Pharms, Slate Run Pharma, Teva Pharms Usa, Xellia Pharms Aps, Steriscience, Zhejiang Novus Pharm, Samson Medcl, and Baxter Hlthcare, and is included in fifty-four NDAs. It is available from twenty-five suppliers. Additional details are available on the VANCOMYCIN HYDROCHLORIDE profile page.
The generic ingredient in VANCOMYCIN HYDROCHLORIDE is vancomycin hydrochloride. There are twenty-two drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.
The generic ingredient in VANCOMYCIN HYDROCHLORIDE is vancomycin hydrochloride. There are twenty-two drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.
Summary for 215338
| Tradename: | VANCOMYCIN HYDROCHLORIDE |
| Applicant: | Amneal |
| Ingredient: | vancomycin hydrochloride |
| Patents: | 0 |
Suppliers and Packaging for NDA: 215338
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | FOR SOLUTION;ORAL | 215338 | ANDA | Amneal Pharmaceuticals NY LLC | 69238-2261 | 69238-2261-3 | 80 mL in 1 BOTTLE (69238-2261-3) |
| VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | FOR SOLUTION;ORAL | 215338 | ANDA | Amneal Pharmaceuticals NY LLC | 69238-2261 | 69238-2261-5 | 300 mL in 1 BOTTLE (69238-2261-5) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SOLUTION;ORAL | Strength | EQ 250MG BASE/5ML | ||||
| Approval Date: | Jun 23, 2023 | TE: | AA | RLD: | No | ||||
Complete Access Available with Subscription
